KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Abbott Laboratories (ABT) Change in Accured Expenses (2009)

Abbott Laboratories recorded quarterly Change in Accured Expenses of $422.4 million in Q4 2009.

Abbott Laboratories' Change in Accured Expenses history runs 1 years deep, the most recent figure standing at $422.4 million for Q4 2009.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Accured Expenses (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	-
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	-654.00 Mn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	703.00 Mn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	-512.00 Mn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	-347.10 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	21.07 Mn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	145.10 Mn
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	-250.00 Mn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	74.30 Mn
10	Zimmer Biomet Holdings	16.17 Bn	15.75 Bn	1.51 Bn	-183.00 Mn

Historic Data

Download Data 🔒

Date	Value
Dec 31, 2009	422.42 Mn
Dec 31, 2009	422.42 Mn